The young febrile infant is at risk for serious infections. Older risk stratification strategies have involved extensive, invasive work-ups. New research from the PECARN group has allowed for a simpler evaluation of the full term, well appearing febrile young infant using only blood and urine testing. Sol sits down with fellow EM physician, and founding chair of the PECARN network, Dr. Nate Kuppermann to discuss the latest trends in evaluating this high risk population.
Tags Child and adolescent care · emergency medicine EM · Emergent/Urgent Care · Evidence based medicine EBM · MOCA OBJECTIVE